Intermittent fasting for improving psoriasis and psoriatic arthritis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of intermittent fasting on the severity of psoriasis and psoriatic arthritis in patients at Ohio State University. Participants will be randomly assigned to either an intermittent fasting group or a standard diet group for 24 weeks. The study will assess changes in disease severity and quality of life through clinical evaluations and patient-reported outcomes. Follow-up assessments will occur every four weeks, with a focus on the feasibility of a larger study based on the results.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* 18 years of age and older
* Established patient at the clinical site with a diagnosis of mild to moderate plaque psoriasis despite treatment
* Ability to consent and follow dietary instructions
* Overweight (BMI ≥ 25)
* No change in systemic psoriasis treatment for 6 weeks

Exclusion Criteria:

* Pregnancy and/or breastfeeding
* Insulin-dependent diabetics
* Severe heart, kidney, and liver disease
* Obesity due to medical condition
* Use of medical treatment for weight reduction

Where it's running

• The Ohio State University Wexner Medical Center
  Columbus, Ohio, United States Recruiting

Study contacts

• Principal investigator: Benjamin H Kaffenberger, MD, MS — Ohio State University
• Study coordinator: Ashley N Gray, BS
• Email: ashley.gray@osumc.edu
• Phone: 6142931707

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• TRAF3IP2 gene variation (rs13190932) in people with psoriasis and psoriatic arthritis

  This trial will test whether the TRAF3IP2 (rs13190932) gene variant changes how adults with psoriasis or psoriatic arthritis respond to methotrexate treatment.

  Recruiting South Valley University · Qina · NCT07086924

• Observational study on psoriasis and its risk for arthritis

  This study is trying to find out which adults with psoriasis are more likely to develop psoriatic arthritis so that steps can be taken to prevent it.

  Recruiting University of Oxford · Oxford, Oxfordshire · NCT05858528

• Examining cytokine levels in psoriasis and psoriatic arthritis patients

  This study is trying to see how certain proteins in the blood and skin of people with psoriasis and psoriatic arthritis can help us understand these conditions better.

  Recruiting Poitiers University Hospital · Poitiers · NCT05307809

• Educational tool for melanoma patients with autoimmune diseases

  This study is testing a new educational tool to help melanoma patients with autoimmune diseases understand their treatment options better and see how easy it is for them to use.

  Recruiting M.D. Anderson Cancer Center · Houston, Texas · NCT04751396

• Understanding chronic inflammatory systemic diseases and their treatments

  This study looks at patients with chronic inflammatory diseases to see how these conditions are related and how they can be treated better.

  Recruiting Centre Hospitalier Universitaire de Besancon · Besançon · NCT04191395

• Using nivolumab to treat patients with autoimmune disorders and advanced cancer

  This study is testing if nivolumab can safely help people with autoimmune disorders who also have advanced cancer by looking at how well it works and what side effects it might cause.

  Recruiting at 40 sites Phase 1 National Cancer Institute (NCI) · Birmingham, Alabama and 51 other locations · NCT03816345

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.